Helen Hongyuan Mao

Title: Helen Hongyuan Mao: Innovator in Antibody Technology

Introduction

Helen Hongyuan Mao is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries and optimization methods. With a total of 4 patents, her work has advanced the understanding and application of antibodies in various medical and research contexts.

Latest Patents

Helen's latest patents include innovative methods for creating combinatorial antibody libraries. These methods utilize human germline segments to compile libraries of nucleic acid molecules that encode variable light (VL) and heavy (VH) chains. The resulting antibody libraries are addressable and can be screened against target protein antigens. Additionally, she has developed methods for affinity maturation-based antibody optimization, which rationally evolve the activity of antibodies to improve their binding affinity for specific target antigens.

Career Highlights

Throughout her career, Helen has worked with notable companies such as Fabrus, Inc. and Taurus Biosciences, LLC. Her expertise in antibody technology has positioned her as a key figure in the biotechnology sector, contributing to advancements that have the potential to impact therapeutic development.

Collaborations

Helen has collaborated with esteemed colleagues, including Vaughn V Smider and Tyson Chase. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Helen Hongyuan Mao's contributions to antibody technology exemplify her dedication to innovation in biotechnology. Her patents and collaborative efforts continue to influence the field, paving the way for future advancements in medical research and applications.